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GROWTH RATES: INFLUENCE OF PREDNISOLONE,
SEX AND CROWDING IN RATS
Karen M. Allen, M.A.
Western Michigan University, 1983
Growth inhibition As frequently noted in the chronically ill child.
Causes of such growth rate decrements appear multiple and include both
internal and environmental factors. The present study analyzed growth
of rats by manipulation of g}ucocorticoid treatment, housing conditions
and sex of subject in a search for potential interactions. Specifi
cally, body weights were assessed daily in post-weanling male and fe
male Spraque-Dawley rats which received 16 daily I.P. injections of
prednisolone acetate (0.0, 2.0, or 4.0 mg/kg) under either individual
or group-housed (6/cage) conditions. Effects of dose and of sex were
found, while a main effect of housing was lacking. Interactions of
dose X housing, as well as dose X sex, were demonstrated. Results are
discussed in terms of alterations in protein synthesis, bone growth,
and growth hormone as influenced by glucocorticoids.

Also discussed

are stress and housing effects on growth, as well as possible mecha
nisms for the noted sex X housing X dose interaction.
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CHAPTER
INTRODUCTION
Decreased growth rates have been observed in-chronically ill
children receiving glucocorticoid and other treatments (e.g., Cheek,
1968; Falliers, Tan, Szentivanyi, Jorgensen, and Dukantz, 1963).

Often

the cause of such decrements has remained obscure, perhaps due in part
to growth's multiple determination.

Both intrinsic and extrinsic in

fluences can be simultaneously operative, and may interact to change
growth rates.
mic variables.

One major set of factors modulating growth is organis
Age-related factors, for instance, are important deter

minants (Cheek, Migeon, and Mellits, 1968).

Gender and associated hor
For example, matura

monal status are well-known growth modulators.

tional changes such as skeletal proportion, fusion of the epiphyses,
growth of the genital organs and secondary sex characteristics are sex
hormone-dependent (Williams, 1974).

Generally sex differences exist

for both height and weight (Marshall, 1970).

Medicinal treatment is

a second major set of variables which can alter growth in the chroni
cally ill child.

Various drug therapies have been increasingly suspec

tet of iatrogenic growth complication.

For example, chronic (1.0 yr. +)

methylphenidate treatment of hyperactive children has been demonstrated
to suppress growth (Mattes and Gittelman, 1983). In addition, clini
cians have long noted growth inhibition as a prominent side-effect of
corticosteroid therapy, yet the mechanism by which this effect occurs
remains unknown (e.g., Haynes and Murad, 1980).

A third major set of
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growth modulators is those environmental and physiological stressors
which may act upon the chronically ill.

Adverse familial environments.

including those marked by abuse and neglect, are now believed to be
the cause of decreased growth in a group of children originally diag
nosed as suffering from idiopathic hypopituitari-sm (e.g., Powell, Bra
sel, and Blizzard, 1967).

When such a child is removed from those cir

cumstances, there generally occurs a period of rapid
and maturation (e.g., Talbot and Sobel, 1947).

1

1

catch-up 11 growth

Potent physiological

stressors may also impact on growth and may include nephrosis and heart
disease (Cheek, 1968) among several other disorders (e.g., Cheek, 1968).
The role of environmental and physiological stressors in decreased
growth, thus also appears potentially significant, but has remained
largely unexplored.
In laboratory animal models, the influence of selected growth
altering variables have been analyzed, usually in isolation.

Gluco

corticoids have been shown to abate growth in various rodent studies.
For instance, daily prednisolone treatment has produced dose-related
systemic toxicities as indexed by marked decrements in total body mass
of weanling male rats (Sewell, Gallus, and Nanry, 1982).

Other studies

have reported glucocorticoid effects on growth of the skeletal system,
and of long bones in particular (Becks, Simpson, and Li, 1944).
Additionally, as in children, a variety of environmental stressors
have been associated with growth abatement in non-human subjects.
Animals raised in darkness, or subjected to excessive noise, have
shown growth inhibition (e.g., Eayrs and Ireland, 1950; Sackler, 1959).
The effect of housing condition on growth has been repeatedly explored
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(e.g., DeFeundis, 1975; Sobel, Zuppinger, and Joss, 1979).

Crowded

gerbils have been noted, for example, to weigh less and have higher
cortisol levels than those housed in pairs (Hull, Kastaniotis,
L!Hommedieu, and Franz, 1976).

Population size has also been demon

strated to markedly affect growth in mice (Christian, 1955).

Further,

gender effects on growth in animals have been noted in a wide range of
species.

Reutter (1976), for instance, attributes sex-differences in

rat size to a slightly more than one week longer cell proliferative
period in males.

In sum, animal studies have shown that, as in the

human clinical case, factors such as gender, environmental stress, and
drug treatment may act by themselves to produce decreased growth.

Cer

tain combinations of such variables have been studied, but the inter
active influence of other variables-in-combination has remained obscure.
As noted, adverse 1 iving environments and glucocorticoid treatment
can act alone to suppress growth; whether these will interact to yield
additive or supra-additive growth decrement is not known.

That housing

condition can markedly alter other toxic reactions to various drug
challenges, has been found repeatedly (e.g., Gallus, Sewell, Nearchou,
and Gault, 1982; Poling, Kesselring, Sewell, and Cleary, 1983).

A

growth-altering interaction between glucocorticoid treatment and sex
is also plausible since effects of corticosteroids are modulated by the
sex hormones in various assays.

For example, androgens are known to

antagonize certain metabolic effects of the glucocorticoids (e.g., Rubenstein and Wayne, 1980).

Further, human females are reported more

prone to develop corticosteroid-induced psychological dysfunction than
are males (Ling, Perry, and Tsuang, 1981).

More generally, sex has
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been demonstrated as an important determinant of drug action employ
ing numerous other dependent measures.

An example of this was found

with parachloroamphetamine toxicity in mice, wherein a significant
sex by dose interaction was noted (Kesselring, Sewell, Gallus, Stiger,
and Nearchou, 1983).

McGovern et al. (1981) have reported differen

tial toxicity of the anti-neoplastic acivicin, as a function of sex
in mice.

Other interactions of drug by sex have been reported for

hexabarbital and pentobarbitol anesthesia, and for strychine and picro
toxin toxicity (see Kato, 1975).

Thus, while the effect of sex on

several drugs• actions has been demonstrated, potential interaction
between glucocorticoid treatment and sex on growth rates has not been
examined.
A related interaction which may affect growth is that between en
vironmental stressors and sex.

Studies have been conducted on the

modulatory influence of gender on behavioral and physiological reac
tiong to noxious stimuli, including over-crowding.

In one such experi

ment, group-housed female rats consumed more alcohol and had higher
corticosterone levels than did grouped males (Hannon and Bolter, 1980).
Whether these stressors interact with gender to change growth is un
known.

It is thus plausible that glucocorticoid treatment, sex, and

environmental stressors together may interact to suppress growth, in
at least an additive manner.

Therefore, with rodent subjects, the

present study explored the influence on prednisolone dose, sex of sub
ject, and crowding in the home cage, as these acted alone and in con
cert, to modify somatic growth.

CHAPTER 11
METHODS
Subjects
Seventy-two male and female, post-weaning, Sprague-Dawley rats
were employed.

Mean body weight on day one of study was 117.3 ± 8.6 gm.

Rapidly growing rats were selected in an effort to maximize potential
evidence of systemic toxicity.

Subjects were bred and raised in our

colony and then were randomly assigned to various drug-environment
conditions.

Subjects were housed either individually or in groups of

six, with unlimited access to rat chow (Rat Chow 5012, Ralston-Purina
Company, St. Louis, MO) and water in a constantly illuminated colony
room maintained at 24-25 ° C.
Apparatus
Rats were housed in stainless steel cages (15 cm wide, 22 cm deep,
and 21 cm high) (Unifab Corp., Kalamazoo, Ml) located in the colony
room.

A food hopper and water bottle were attached to each cage.

Individual body weights were determined with a top-loading scale (Pel
ouze, model 1000).
Procedure
The experiment employed a "group design", wherein various, ran
domly selected groups of rodents were assigned to combinations of
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three different treatment or subject variables, these being sex of
subject, housing condition and dose of drug.

Rodents were housed

individually or six per cage for five days to establish baseline
weights before receiving any injections.
the same from then on.

Housing conditions remained

For 16 consecutive days, -animals were weighed

daily and then injected with one of three prednisolone acetate doses
(0.0, 2.Q, or 4.0 mg/kg) (see Table 1).
Table 1
The drug dosage, sex, housing condition, and
number of subjects for each group tested.

Group

Drug

Dose
(mg/kg)

Sex

Housing
Condition

N

Saline

Male

Group

6

2

Sa 1 ine

Female

Group

6

3

Prednisolone

2.0

Male

Group

6

4

Prednisolone

2.0

Female

Group

6

5

Prednisolone

4.0

Male

Group

6

6

Prednisolone

4.0

Female

Group

6

7

Saline

Male

Individual

5

8

Sa 1 ine

Female

Individual

7

9

Prednisolone

2.0

Male

Individual

5

10

Prednisolone

2.0

Female

Individual

7

11

Prednisolone

4.0

Male

Individual

5

12

Prednisolone

4.0

Female

Individual

7

7
Drug Preparation and Administration
Stock suspensions of prednisolone acetate (50 mg/ml) (Carter
Glogan, Glendale, AZ) were diluted with physiological saline to concen
trations of 2.0 and 4.0 mg/ml and administered at 1.0 ml/kg volumes
by intraperitoneal injection.

These doses were chosen as previous

research has shown them active in various assays with rodent subjects
(Silverman and Maori, 1979).

In addition, the lower dose (2.0) is

within the clinical range used in the treatment of various human
pathologies (Graef and Cone, 1978).
Statistical Analysis
Daily absolute body weight data and net changes in weight across
study were analyzed by use of three-way analysis of variance (AN0VA)
techniques (Hopkins and Glass, 1978).

Results were reported graphi

cally as group means ± one standard error.

CHAPTER I I I
RESULTS
Effects of Prednisolone, Housing Condition and
Sex on Absolute Body Weight
Figure 1 shows the effects of prednisolone, sex, and housing
condition on absolute body weights taken on the final day of study.
Weight was lower for group-housed females, at all dosage levels, than
for the individually housed females and for all males.

Male weights

decreased as dosage increased and in those subjects that were group
housed.

Three-way AN0VA indicated the existence of significant effects

regarding dosage level (F (2,60) = 41.425, pL 0.000), sex (F (1,60) =
295.923, pL 0.000), and housing X sex (F (1,60) = 4.623, pl 0.035).
However, no significant effects were found for housing in isolation
or for interactions of (a) Dose X Housing, (b) Dose X Sex, or (c) Dose
X Sex X Housing.
Effects of Prednisolone, Housing Condition and
Sex on Grams-Change from Baseline Weight
The interaction of prednisolone, housing and sex had marked influ
ence on weight gain during the 16 days of study.

As shown in Figure 2,

growth, as indexed by weight gain, was less as dose of prednisolone
increased, for both male and female subjects.

Males gained more weight

than females in all three drug treatments and both housing conditions.
Statistical analysis via three-way AN0VA indicated highly significant
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effects of dosage level (F (2,60) = 39,097, p- 0.000), sex (F (1,60) =
283.488, p- 0.000), as well as a significant dose X housing interaction
(F (2,60) = 4,833, p� 0.0ll)·was evident.

Further, a significant dose

X housing X sex interaction (F (2,60) = 4.833, p- 0.011) was evident.
No significant influences were revealed, however, for (a) housing in
isolation, (b) dose X sex interaction, or (c) housing X sex.

Figure 3

shows the difference in mean weights for male and female subjects for
both housing conditions, and the three drug levels.
males weighed more than the females.

In all cases the

Body weight for males was greater

in subjects that were individually housed than for those that were
group housed in the lower dose group (2.0) and saline-treated subjects.
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Effects of prednisolone treatment (0.0, 2.0, or 4.0 mg/kg)
on mean absolute weight difference between sexes in grouped
and individual housing conditions. For each comparison,
male weight was greater than female.

CHAPTER IV
DISCUSSION
Daily prednisolone yielded systemic toxicit1es as evidenced by
marked growth decrements, across the 16 days of study. Weight loss
accrued as number of drug treatments, and as dose increased (see
Figures 1, 2, and 3).

This general result corroborates several pre

vious reports of growth-detrimental effects in both children (Blodgett
et al., 1956; Falliers et al., 1963; Liddle et al., 1974; Thomas and
Mawhinney, 1973; Sobel, 1956) and laboratory animal subjects (Becks,
Simpson, Li, and Evans, 1944; Parmer, Katonah, and Angrist, 1951;
Sobel, 1958; and Wells and Kendall, 1940; Sewell et al., 1982). The
mechanisms by which the glucocorticoids affect growth appear numerous
and are disparate enough such that no unitary hypothesis of action is
possible at this time (e.g., Melby, 1977). One well-known set of glu
cocorticoid effects is on protein metabolism (e.g., Liddle and Melman,
1974; Loeb, 1976; Baxter and Forsham, 1972).

Glucocorticoids markedly

enhance amino acid metabolism by (a) increasing mobilization from
extra-hepatic tissues, and (b) incrementing synthesis of catabolic
enzymes (e.g., Haynes and Murad, 1980; Parson, Crispell, and Ebbert,-1952).

In reaction to high circulating glucocorticoid levels, protein

synthesis is inhibited (Baxter et al., 1972; Clark, 1953; Deane, 1962),
possibly in relation to observed decrements in extrahepatic RNA forma
tion (e.g., Guyton, 1979) and/or amino acid uptake (Baxter et al., 1972;
Clark, 1953; Ganong and Martini, 1973).
13

Negative nitrogen balance
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(Siber and Porter, 1953) may be due in part to amino acid deamination
(Baxter et al., 1972; Parson et al., 1952).

Altered protein metabo-

1 ism is thus suggested as one important mediator of the prenisolone
induced weight losses here reported.
A second major effect of glugocorticoids on growth is osteoporosis
that occurs as a consequence of catabolism and anti-anabolism of bone's
protein matrix (Guyton, 1979).

An imbalance in which bone destruction

exceeds new bone formation is a result of glucocorticoid-induced reduc
tion of RNA and protein synthesis in collogen-synthesizing cells (Tal
mage, Owen, and Parsons, 1975).

Glucocorticoids further decrease bone

growth via depression of calcium uptake by intestine and inhibiting
calcium reabsorption by kidney (Salhanick, Kipnis, and Vande Wiehle,

1969).

Another skeletal effect is the direct inhibition of mitosis

in osteoprogenitor cells (Rassmussen and Bordier, 1974).

In addition,

glucocorticoid treatment may result in premature closure of the epiphy
seal plates of long bones, thus yielding an irreversible shortening of
stature (Liddle et al., 1974).
A third means by which glucocorticoid therapy may lead to growth
retardation is the inhibition of growth hormone secretion.

Large doses

of glubocorticoids reduce somatotrophin (5TH) secreted, amount of soma
tomedin formed in response to STH administration, and effect of soma
tomedians on cartilage (Pecile, Mueller, 1972; Daughday, Harrington
and Phillips, 1975).

Further, it is possible that amounts of gluco

corticoid sufficient to promote such changes are released by the adrenal
cortex in times of stress (Martin, 1976).
In the present experiment, one-half the subjects were group-housed
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in an attempt to assess the influence of crowding stress.

Housing was

found to interact with sex and prednisolone dose in determination of
body weight.

Inspection of Figures 1 and 3 clearly display this result.

A main effect of housing per se, was not found, however, and this later
result is in keeping with previous work (e.g., Sobel et al., 1979;
Latane, Cappel 1, and Jay, 1970).

That some relation exists between

environmental aversive stimuli and growth rates may have been inferred
from assorted clinical reports of

11psychosocial

dwarfism11 , or the

failure-to-thrive11 syndrome (e.g., Fried, 1949; Patton and Gardner,

11

1962; Talbut et al., 1947; Powell, Brasel, and Blizzard, 1967).

Crowd

ing stress has often been implicated in growth inhibition in animals
(Jean-Faucher, Berger, Deturckheim, Veyssiere, and Jean, 1981; Hull et
al., 1976).

Other aversive environmental stimuli have also been noted

to yield growth decrements including hypozia (Hunter and Clegg, 1973),
excessive noise (Sackler, 1959), and darkness ([ayrs and Ireland, 1950).
Christian (1955) attributes a decline in body weight which accom
panied increasing population density to a general non-specific reaction
to crowding.

Various studies which have employed dense housing have

also shown increased adrenal and decreased gonadal activity. There
are several plausible mechanisms by which crowding stress may inter
fere with growth.

It is reasonable, for instance, that crowding may

have been sufficient to produce changes in STH secretion and somatome
dian formation and/or release, directly.

This effect may have been

further enhanced by aforementioned glucocorticoid influences.
A second plausible mechanism has to do with crowding having
decreased food and/or water consumption in the group-housed, as compared
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to individually housed subjects.

That food and water remained continu

ally available to all subjects decreases this 1 ikelihood, still, domi
nance heirarchies do develop in group-housed rodent populations and
these may alter consumption patterns.
A third plausibility is that crowding stress may yield central
nervous system effects which then change secondary metabolism via anter
ior pituitary mediation (e.g., of thyroid or gonadal effects).

These

plausibilities require examination.
Sex of subject was also an important factor in the growth changes
here reported.

Figures 1 and 2 demonstrate that within each sex, as

dose of prednisolone increased so too did the amount of growth decrease.
Thus, the present study extended to females the previous finding in
weanling males that prednisolone inhibits growth (Sewell et al., 1982).
Figure 2 shows also, however, that for each comparison, male weight was
greater than that for females.

Figure 3 emphasizes that this average

weight difference was a clear function of both housing condition and
dose, and that as dose increased, the degree of this sex difference
abated.

Statistical analysis revealed a significant 3-way interaction

between sex, housing condition, and dose.

Thus, the degree of sex

difference was dependent upon environmental context, and this environ
menta� influence was negated by increased prednisolone dose (see Fig
ure 3).

The mechanism(s) by which gender interacts with housing and

prednisolone dose to determine growth rates remains speculative.

How

ever, it is plausible that differences in sex hormones are relevant.
For instance, testosterone, an anabolic steroidal hormone, promotes
(a) retention of nitrogen and electrolytes, (b) protein synthesis, and

-·
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(c) growth and strengthening of skeletal muscle (Martin, 1976).

Ani-

mal crowding studies which show an increase in testicular weights,
show a decrease in plasma testosterone levels (Jean-Faucher et al.,
1981).

High circulating glucocorticoids during development can alter

testicular morphology and function (Paulsen, 1974).

Lowered testoster-

one levels as a result of crowding stress and glucocorticoid treatment,
may have been a gender-dependent cause of the growth retardation here
reported.

This possibility awaits analysis, perhaps through castration

and androgen replacement procedures.
affected by stressful events.

Estrogen levels may also be

A variety of stimuli, including rape,

have been effective in producing spontaneous ovulation (Balin, 1972).
During spontaneous ovulation, estrogens rise at a critical rate (Greep,
1973).

In response to excess estrogen, cartilage growth is decreased

and the epiphyses of the long bones calcify prematurely (Williams,
1974).

Further, high doses of estrogen decrease growth by reducing

somatomedian synthesis but do not inhibit its action (Pecile et al.,
1972).

Sex hormones thus can have a decided effect on growth.
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